How do I buy Rhythm Pharmaceuticals (RYTM) stock?

You can purchase shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) through any online brokerage.View our list of the best stock brokerages

Who are Rhythm Pharmaceuticals (RYTM) competitors?

Other companies in Rhythm Pharmaceuticals’s space includes: Immunovant Inc (NASDAQ:IMVT), Avidity Biosciences Inc (NASDAQ:RNA), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC) and Alkermes PLC (NASDAQ:ALKS).

What is the forecast, or price target, for Rhythm Pharmaceuticals (RYTM) stock?

Rhythm Pharmaceuticals has a consensus price target of $119.69.

What is the current price for Rhythm Pharmaceuticals (RYTM)?

The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $101.63 last updated January 16, 2026 at 4:00 PM EST.

Does Rhythm Pharmaceuticals (RYTM) pay a dividend?

There are no upcoming dividends for Rhythm Pharmaceuticals.

When is Rhythm Pharmaceuticals (NASDAQ:RYTM) reporting earnings?

Rhythm Pharmaceuticals does not have any upcoming earnings scheduled.

Is Rhythm Pharmaceuticals (RYTM) going to split?

There is no upcoming split for Rhythm Pharmaceuticals.

What sector and industry does Rhythm Pharmaceuticals (RYTM) operate in?

Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rhythm Pharmaceuticals (RYTM) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

Comments